ARTHEX BIOTECH

Investigating antimiRs to treat diseases with unmet medical needs

Valencia · Founded 2019 · $94.4M raised

Headquarters
Valencia
Founded
2019
Business Model
B2B
Total Funding
$94.4M
Last Round
$4.9M Venture RoundSep 2025
Rounds
3

About

ARTHEx Biotech is a clinical-stage biotechnology company spun off from the University of Valencia, focused on developing innovative medicines through modulation of microRNA expression (antimiRs). The company investigates antisense RNA compounds designed to treat diseases with unmet medical needs, including a lead program for myotonic dystrophy type 1 (DM1). Arthex is headquartered in Valencia, Spain, led by CSO and co-founder Beatriz Llamusí.

Summary

ARTHEX BIOTECH is a Biotech company based in Valencia, founded in 2019. It has raised $94.4M in total across 3 rounds, most recently a $4.9M Venture Round round in Sep 2025. Investors include European Innovation Council Fund, Invivo Capital Partners and Bpifrance.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BSep 2025
$87.0M

Sign up to see all 3 rounds

Venture Round through Series B — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

ARTHEX BIOTECH on Indexed.vc
<a href="https://indexed.vc/companies/arthex-biotech"><img src="https://indexed.vc/api/badge/company/arthex-biotech" alt="ARTHEX BIOTECH on Indexed.vc" width="260" height="76" /></a>